Porton Biopharma

Biopharmaceutical Product Development from Research to Clinic

Construction Starts on New Developmental Facility for Porton Biopharma

In a ceremony led by Baroness Scott of Bybrook OBE, Porton Biopharma (PBL) has begun construction of a new pharmaceutical development facility, which will provide state-of-the-art facilities...

Construction Starts on New Developmental Facility for Porton Biopharma

Construction Starts on New Fermentation Facility at Porton Biopharma

In a ceremony led by Salisbury's MP John Glen, Porton Biopharma has initiated construction of a new multi-million...

Construction Starts on New Fermentation Facility at Porton Biopharma

Opening of the Pharm-Stores Extension Demonstrates Investment in Porton Biopharma

Chairman of the Porton Biopharma (PBL) Martin Hindle opened an extension of its facility for the storage of raw...

Opening of the Pharm-Stores Extension Demonstrates Investment in Porton Biopharma

Next Steps for Porton Biopharma's Erwinase® Taken in Japan

Ohara Pharmaceutical have submitted a new drug application for PBL's Erwinase® in...

Next Steps for Porton Biopharma's Erwinase® Taken in Japan

Minister for Life Sciences George Freeman Opens Porton Biopharma Manufacturing Facility

A new mutli-million pharmaceutical manufacturing facility has been opened at Porton Biopharma...

Minister for Life Sciences George Freeman Opens Porton Biopharma Manufacturing Facility

Public Health England to Transfer its Drug Development and Production to Porton Biopharma

The transfer of Public Health England's (PHE) clinical drug development and production capability into a standalone, state-owned biopharmaceutical limited company has been approved by the...

Public Health England to Transfer its Drug Development and Production to Porton Biopharma